Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

1.32
Delayed Data
As of Aug 23
 -0.06 / -4.35%
Today’s Change
1.25
Today|||52-Week Range
7.54
-58.61%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Brown Dennis M
Chief Scientific Officer
Sale1/31/2017125,000$1.54$192.5K-71.86%
Bacha Jeffrey A
Chief Executive Officer
Buy6/26/20176,700$3.60$24.1K-39.45%
Bell John K
Director
Buy6/06/201710,000$2.12$21.2K-35.29%
Bacha Jeffrey A
Chief Executive Officer
Buy2/01/20174,000$5.00$20.0K-74.38%
Praill Scott
Chief Financial Officer
Buy6/06/20179,500$2.10$20.0K-35.29%
Bell John K
Director
Buy6/26/20174,167$3.60$15.0K-39.45%
Mohr Erich
Director
Buy6/26/20174,167$3.60$15.0K-39.45%
Praill Scott
Chief Financial Officer
Buy6/26/20174,167$3.60$15.0K-39.45%
Bacha Jeffrey A
Chief Executive Officer
Buy6/06/20175,000$2.12$10.6K-35.29%
Cranston Lynda
Director
Buy6/26/20172,083$3.60$7.5K-39.45%
Page of 2